ロード中...
Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)
BACKGROUND: Management of metastatic melanoma is changing rapidly following the introduction of innovative effective therapies, with consequences for the allocation of healthcare resources. The objective of this study was to assess hospitalisation costs of metastatic melanoma in France from 2011 to...
保存先:
| 出版年: | BMC Health Serv Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5549336/ https://ncbi.nlm.nih.gov/pubmed/28789648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2472-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|